Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lucy, Shneyer"'
Publikováno v:
Open Access Journal of Clinical Trials. 9:41-57
Yong Yue,1 Kenneth D Reed,1 Lucy Shneyer,2 Dongzhou J Liu3 1GlaxoSmithKline Consumer Healthcare, Parsippany, NJ, 2Shneyer Statistics LLC, Denville, NJ, 3GlaxoSmithKline, Collegeville, PA,USA Objectives: Two randomized placebo-controlled trials evalua
Autor:
Anto, Jose, John, Ward, Lucy, Shneyer, Jacob, Skinner, Nathan, Jeal, Matthew, Cronin, Mary Lynn, Bosma
Publikováno v:
The Journal of clinical dentistry. 27(1)
To evaluate the oral tolerance of three experimental toothpaste formulations containing sodium fluoride (NaF), compared with two marketed sodium monofluorophosphate (SMFP)-containing biotène® toothpastes, in a dry mouth population after 14 days (pr
Publikováno v:
BDJ Open
Objectives/Aims: To evaluate continuous and episodic twice-daily usage regimens of a desensitising dentifrice containing 5% calcium sodium phosphosilicate (CSPS). Materials and Methods: In this exploratory, single-centre, randomised, examiner-blind s
Autor:
Lucy Shneyer, Pascale Reidenberg, Chin-Chung Lin, Elaine Radwanski, Melvin D. Brannan, Mitchell N. Cayen, Melton B. Affrime
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:269-278
Objective To evaluate the effects of coadministration of loratadine and erythromycin on the pharmacokinetics and electrocardiographic repolarization (QTc) pharmacodynamics of loratadine and its metabolite descarboethoxyloratadine in healthy volunteer
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 4(4):682-688.e6
Background In 2013, the Agency for Healthcare Research and Quality (AHRQ) recommended that allergic rhinitis (AR) studies calculate a minimal clinically important difference (MCID) based on an estimated threshold equal to 30% of the maximum total nas
Publikováno v:
Statistics in medicine. 20(7)
This paper considers the mixture model methodology for handling non-ignorable drop-outs in longitudinal studies with continuous outcomes. Recently, Hogan and Laird have developed a mixture model for non-ignorable drop-outs which is a standard linear
Autor:
D. Robert Webb, Stuart M. Garay, Jeffrey Leflein, Joe W. Ramsdell, Michael Noonan, J Grossman, William Berger, George W. Bensch, Anthony R. Rooklin, David F. Graft, Arthur C. DeGraff, Judy E. Harrison, Richard G. Gower, Lucy Shneyer, Evangelo Frigas, Keith B. Nolop, Jill P. Karpel, Eric J. Schenkel, Robert A. Nathan, Bernard Silverman, David I. Bernstein, Edwin A. Bronsky, Timothy J. Craig, James E. Fish
Publikováno v:
The Journal of allergy and clinical immunology. 106(5)
Inhaled corticosteroid therapy in severe persistent asthma has been shown to reduce or eliminate oral corticosteroid (OCS) use while retaining effective asthma control.We sought to evaluate the ability of mometasone furoate (MF) delivered by means of
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
Autor:
Charles H. Banov, David S. Pearlman, Anjuli Nayak, Judy E. Harrison, Anthony T. Scardella, Gregory Gottschlich, Bernard Silverman, Alan B. Goldsobel, Barry K. Feinstein, Michael S. Lawrence, Bruce F. Friedman, Eric J. Schenkel, William R. Lumry, Allen T. Segal, Robert J. Lapidus, Zev M. Munk, Lucy Shneyer, Kathy L. Lampl, Anthony A. Floreani, Nathan Segall, Paul J. Hannaway, Jonathan Corren, Keith B Nolop
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 84(4)
Background Although inhaled glucocorticoids are recommended for all stages of persistent asthma, compliance with long-term therapy is often poor, leading to significant morbidity and mortality. A simplified, once-daily dosing regimen may foster impro